Function of Membrane Type Matrix Metalloproteinase

膜型基质金属蛋白酶的功能

基本信息

  • 批准号:
    9896984
  • 负责人:
  • 金额:
    $ 37.05万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1997
  • 资助国家:
    美国
  • 起止时间:
    1997-06-11 至 2024-11-30
  • 项目状态:
    已结题

项目摘要

Abstract The most deadly characteristic of cancer cells is their ability to invade local tissues and metastasize. Current evidence suggests that carcinoma cell proliferative, invasive and metastatic potential are regulated in a cancer cell-autonomous fashion as well as by the surrounding cellular and acellular microenvironment. Using MT1-MMP conditional knockout mice, in combination with human patient- derived cancer xenografts, we have recently reported that carcinoma cell-derived MT1-MMP plays a dominant role in driving local tissue invasion and metastasis. Unexpectedly, however, we find that targeting carcinoma cell MT1-MMP alone in vivo triggers large scale changes in the transcriptional program of the cancer cells that extend far beyond the regulation of cell-extracellular matrix (ECM) interactions. These results suggest that MT1-MMP exerts a more global effect on carcinoma cell function than previously appreciated. Indeed, we provide new evidence that MT1-MMP controls carcinoma cell gene expression by regulating a novel mechanotransduction cascade that centers on the regulation of nuclear lamin A/C level with attendant effects on the co-transcriptional activators, YAP and TAZ and the MRTF-SRF transcriptional network. Furthermore, preliminary studies indicate that MT1-MMP exerts these effects in a proteinase-dependent fashion by effecting the remodeling of the type I collagen-rich, interstitial ECM. Finally, while monitoring the trafficking of MT1-MMP to invadopodial structures during ECM remodeling, we have uncovered a heretofore undescribed process wherein MT1-MMP translocates from promyelocytic leukemia protein (PML)-rich nuclear invaginations to ECM-degradative sites at the cell surface in association with the cytoplasmic RNA-binding protein, UNR/CSDE1. Given these findings, we outline plans for a combination of molecular and cellular studies that seek to i) define MT1-MMP as a master upstream regulator of the mechanotransduction-linked carcinoma cell transcription programs required for invasion and metastasis, ii) characterize the role of the MT1-MMP/type I collagen axis as the key determinant responsible for controlling carcinoma cell behavior in vivo and iii) establish the role of a novel, nuclear budding-initiated, MT1-MMP-PML/UNR interaction network in controlling proteinase delivery to matrix-degradative invadosomes. Together, these studies seek to identify MT1-MMP as the dominant proteolytic effector of tumor progression in vivo by virtue of its ability to control the behavior of cancer cell populations embedded within the type I collagen-rich 3D ECM encountered at primary and metastatic sites in vivo.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

STEPHEN J WEISS其他文献

STEPHEN J WEISS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('STEPHEN J WEISS', 18)}}的其他基金

Pericellular Proteolysis and the Regulation of Bone/Tendon Stem Cell Fate
细胞周蛋白水解和骨/肌腱干细胞命运的调节
  • 批准号:
    10371563
  • 财政年份:
    2022
  • 资助金额:
    $ 37.05万
  • 项目类别:
Pericellular Proteolysis and the Regulation of Bone/Tendon Stem Cell Fate
细胞周蛋白水解和骨/肌腱干细胞命运的调节
  • 批准号:
    10677552
  • 财政年份:
    2022
  • 资助金额:
    $ 37.05万
  • 项目类别:
A dual MMP9/MMP14 Axis Regulates Osteoclast Bone Resorptive Function
双 MMP9/MMP14 轴调节破骨细胞骨吸收功能
  • 批准号:
    10202488
  • 财政年份:
    2019
  • 资助金额:
    $ 37.05万
  • 项目类别:
A dual MMP9/MMP14 Axis Regulates Osteoclast Bone Resorptive Function
双 MMP9/MMP14 轴调节破骨细胞骨吸收功能
  • 批准号:
    9896587
  • 财政年份:
    2019
  • 资助金额:
    $ 37.05万
  • 项目类别:
A dual MMP9/MMP14 Axis Regulates Osteoclast Bone Resorptive Function
双 MMP9/MMP14 轴调节破骨细胞骨吸收功能
  • 批准号:
    10663883
  • 财政年份:
    2019
  • 资助金额:
    $ 37.05万
  • 项目类别:
A dual MMP9/MMP14 Axis Regulates Osteoclast Bone Resorptive Function
双 MMP9/MMP14 轴调节破骨细胞骨吸收功能
  • 批准号:
    10016173
  • 财政年份:
    2019
  • 资助金额:
    $ 37.05万
  • 项目类别:
MT1-MMP Regulates Mesenchymal Stem Cell Fate Decisions
MT1-MMP 调节间充质干细胞的命运决定
  • 批准号:
    8759604
  • 财政年份:
    2014
  • 资助金额:
    $ 37.05万
  • 项目类别:
Nuclear MT1-MMP and Macrophage Immune Function
核MT1-MMP与巨噬细胞免疫功能
  • 批准号:
    9173451
  • 财政年份:
    2013
  • 资助金额:
    $ 37.05万
  • 项目类别:
Nuclear MT1-MMP and Macrophage Immune Function
核MT1-MMP与巨噬细胞免疫功能
  • 批准号:
    8630187
  • 财政年份:
    2013
  • 资助金额:
    $ 37.05万
  • 项目类别:
MMP-dependent control of macrophage immune function
巨噬细胞免疫功能的 MMP 依赖性控制
  • 批准号:
    8513680
  • 财政年份:
    2012
  • 资助金额:
    $ 37.05万
  • 项目类别:

相似海外基金

Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中骨-脂肪相互作用
  • 批准号:
    10590611
  • 财政年份:
    2022
  • 资助金额:
    $ 37.05万
  • 项目类别:
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中的骨-脂肪相互作用
  • 批准号:
    10706006
  • 财政年份:
    2022
  • 资助金额:
    $ 37.05万
  • 项目类别:
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中骨-脂肪相互作用
  • 批准号:
    10368975
  • 财政年份:
    2021
  • 资助金额:
    $ 37.05万
  • 项目类别:
BCCMA: Foundational Research to Act Upon and Resist Conditions Unfavorable to Bone (FRACTURE CURB): Combined long-acting PTH and calcimimetics actions on skeletal anabolism
BCCMA:针对和抵抗不利于骨骼的条件的基础研究(遏制骨折):长效 PTH 和拟钙剂联合作用对骨骼合成代谢的作用
  • 批准号:
    10365254
  • 财政年份:
    2021
  • 资助金额:
    $ 37.05万
  • 项目类别:
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中骨-脂肪相互作用
  • 批准号:
    10202896
  • 财政年份:
    2021
  • 资助金额:
    $ 37.05万
  • 项目类别:
BCCMA: Foundational Research to Act Upon and Resist Conditions Unfavorable to Bone (FRACTURE CURB): Combined long-acting PTH and calcimimetics actions on skeletal anabolism
BCCMA:针对和抵抗不利于骨骼的条件的基础研究(遏制骨折):长效 PTH 和拟钙剂联合作用对骨骼合成代谢的作用
  • 批准号:
    10531570
  • 财政年份:
    2021
  • 资助金额:
    $ 37.05万
  • 项目类别:
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage
剖析与年龄和骨关节炎相关的关节软骨合成代谢下降有关的分子机制
  • 批准号:
    10541847
  • 财政年份:
    2019
  • 资助金额:
    $ 37.05万
  • 项目类别:
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage
剖析与年龄和骨关节炎相关的关节软骨合成代谢下降有关的分子机制
  • 批准号:
    10319573
  • 财政年份:
    2019
  • 资助金额:
    $ 37.05万
  • 项目类别:
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage
剖析与年龄和骨关节炎相关的关节软骨合成代谢下降有关的分子机制
  • 批准号:
    10062790
  • 财政年份:
    2019
  • 资助金额:
    $ 37.05万
  • 项目类别:
Promotion of NAD+ anabolism to promote lifespan
促进NAD合成代谢以延长寿命
  • 批准号:
    DE170100628
  • 财政年份:
    2017
  • 资助金额:
    $ 37.05万
  • 项目类别:
    Discovery Early Career Researcher Award
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了